CHADS-P2A2RC 评分则有 24.9% 患者属于高危(≥ 4 分)、48.1% 为中危(2～3 分)、27.0% 为低危(≤ 1 分)。 每100 人年的主要不良心血管事件,两种方案均被认为是高危的患者为 4.8;ESC 标准高危但 CHADS-P2A2RC 低中危的患者为 2.1;ESC 标准低中危而 CHADS-P2A2RC 评分为高危的患者为 3.8;两种标准...
Comparison of CHADS2 score with CHADSVASC-Score in a prospective multicenter registry on patients with atrial fibrillation undergoing coronary artery stenting (AFCAS-trial)A., SchlittA., RubboliJ., ValenciaP., KarjalainenM., WeberM., Puurunen...
CHA2DS2-VASc score was also significantly associated with stroke (HR 1.25; CI 1.12 to 1.40, p<0.001). CHADS2 score (HR 1.46; CI 1.36 to 1.56, p<0.001) and CHA2DS2-VASc score (HR 1.39; CI 1.31 to 1.46, p<0.001) were associated with mortality. Results were still significant after ...
CHADS2 score/CHA2 DS2 -VASc score and major artery occlusion in cardioembolic stroke patients with nonvalvular atrial fibrillation. Ohe et al., "CHADS2 score/CHA2DS2- VASc score and major artery occlusion in cardioembolic stroke patients with nonvalvular atrial fibrillation," ......
【摘要】CHADS2 和 CHA2DS2-VASc 评分是非瓣膜性心房颤动患者卒中风险分 层和指导抗凝治疗的常用工具.最近研究发现上述评分亦可用于预测非心房颤动患 者卒中、不良心血管事件和死亡风险以及临床预后.现就 CHADS2 和 CHA2DS 2VASe 评分相关的临床最新应用做一综述.%CHADS2 and CHA2DS2-VASc score are widely ...
CHADS2和CHA2DS2-VASc评分对非心房颤动心脏疾病患者卒中的预测价值要点 万方数据
目的:研究CHADS2,CHA2DS2-VASc,R2-CHADS2三种评分对我国非瓣膜性房颤患者卒中的风险分层作用,为我国非瓣膜性房颤患者临床口服抗凝治疗提供临床线索和依据.方法:收集20... 魏博 - 重庆医科大学 被引量: 4发表: 2015年 Evaluation of CHA2DS2-VASc score and R2CHADS2 score in patients with acute pulmonary thr...
In patients with a CHADS2 or CHA2DS2-VASc score=1, the rate of stroke/TE was 2.9% and 0.9% respectively, but in patients at "high risk" (... Y Guo,S Apostolakis,AD Blann,... - 《International Journal of Cardiology》 被引量: 129发表: 2013年 Prevenção do tromboembolismo na...
Two simple scores, CHADS2 [4] and CHA2DS2-VASc [5] are commonly used to estimate the risk of stroke in patients with atrial fibrillation (AF) and to identify those who are most likely to benefit from anticoagulation [5]. The CHA2DS2-VASc score has been shown to have a modestly better...
ROC curve analysis identified as predictors of cardioembolic source CHADS2 score ≥4 (sensitivity of 75.0%, specificity of 66.0%, p=0.014) and CHA2DS2-VASc score ≥5 (sensitivity of 83.3%, specificity of 58.0%, p=0.009). Conclusions Both scores showed acceptable sensitivity as predictors of ...